CHNQD-01228

N/A

Report date: 2026/03/06 20:02:51
NME

Base Information

Drug NameCHNQD-01228
Drug Alias NameBrefeldin A 4-O-nicotinateCHNQD-01228CHNQD01228
ClassificationSmall molecules
Mechanisms of ActionADP Ribosylation Factor 1 inhibitorsCytoplasmic tyrosine-protein kinase BMX inhibitors
TargetsADP Ribosylation Factor 1Cytoplasmic tyrosine-protein kinase BMX
Therapy Area/IndicationsUrinary Bladder Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesHainan Normal UniversityOcean University Of China
Inactive CompaniesN/A
Active IndicationsUrinary Bladder Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A